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Temporomandibular joint (TMJ) dislocation can occur during daily activities and negatively aﬀect a 
patientʼs quality of life.  Although both nonsurgical and surgical techniques have been used to treat 
recurrent TMJ dislocation,  the former is not always successful and the latter,  although having a high 
success rate,  is invasive and requires hospitalization.  Recently,  autologous blood injection has been 
used to treat recurrent TMJ dislocation.  However,  this technique is not yet widely used in clinical 
practice.  We designed this study to obtain further information as to eﬃcacy,  safety and stability of 
autologous blood injection for recurrent TMJ dislocation.
Key words: autologous blood injection,  recurrent temporomandibular joint dislocation
T emporomandibular joint (TMJ) dislocation can occur during simple activities such as laughing 
and yawning,  and it may occur after excessive mouth 
opening during dental treatment,  tracheal intubation 
or episodes of vomiting.  There is a higher frequency 
of TMJ dislocation in patients with Parkinsonʼs dis-
ease or cerebrovascular disorders,  which is attributed 
to masticatory muscle incoordination [1].  A person 
with TMJ dislocation is unable to close his mouth,  
which remains locked open until a mechanical reduc-
tion is performed.  Frequent dislocation episodes 
characterize a condition referred to as recurrent TMJ 
dislocation.  Thus,  patients with this problem risk 
TMJ dislocation simply by carrying out their daily 
activities; the disorder can be especially dangerous 
when self-reduction of the TMJ dislocation is diﬃcult 
or impossible.
　 Methods of treating recurrent TMJ dislocation 
range from conservative treatment [2,  3] to surgical 
interventions [4-7].  Conservative treatments such as 
restricting mandibular motion with a chin cap,  an 
elastic facial bandage or maxillomandibular ﬁxation 
often fail to manage the condition.  Whereas surgical 
treatment through eminectomy is considered the gold 
standard in the treatment of recurrent TMJ disloca-
tion with success rates greater than 85  [5,  8].  
Surgical intervention may have a high success rate,  
but it is an invasive procedure requiring general 
anesthesia,  a hospital stay and a skin incision,  in addi-
tion to increased risk of facial nerve injury.
　 Schulz [9] ﬁrst described autologous blood injec-
tion for treating recurrent TMJ dislocation in 1973.  
In Japan,  Takahashi et al.  [10] ﬁrst reported the 
eﬃcacy of autologous blood injection in a compromised 
patient who was unable to receive surgery in 2003.  
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The reported overall success rate of autologous blood 
injection is approximately 80  [8,  11,  12].  The 
action mechanism of TMJ autologous blood injection is 
not fully understood.  However,  the pathophysiologi-
cal reaction to blood injected into the superior joint 
space and the pericapsular tissue of the TMJ would be 
scarring and ﬁbrous tissue formation [13].  Therefore,  
the concept behind autologous blood injection is pro-
motion of ﬁbrosis within the capsular tissue and con-
sequently restraining the motion of mandibular excur-
sion.  Autologous blood injection could be a promising 
alternative to surgery for recurrent TMJ dislocation,  
particularly in patients who are not eligible for surgi-
cal procedures.  However,  the procedure is not yet 
widely used.
Endpoints
　 This study is intended to evaluate the eﬃcacy,  
safety and stability of TMJ autologous blood injection 
for the treatment of recurrent TMJ dislocation in an 
eﬀort to standardize the procedure.  The primary 
outcome is to have no condylar dislocation episodes 
for 6 months following the procedure.  A secondary 
outcome is improving quality of life with a decreased 
frequency of condylar dislocation.
Eligibility Criteria
　 All patients who meet the main inclusion criteria 
without excluding factors will be included in this 
study.  The target sample size will be 5 patients per 
year.  Table 1 lists the main inclusion and exclusion 
criteria [14].  An investigator must obtain written 
informed consent from the patient or the legally autho-
rized representative before the procedure.  This study 
follows the Declaration of Helsinki on medical proto-
col and ethics.  The Ethics Committee of Okayama 
University Graduate School of Medicine,  Dentistry 
and Pharmaceutical Sciences and Okayama University 
Hospital approved this studyʼs protocol (Approval 
No.1108).  UMIN registration number: 000022197.
Treatment Methods
　 This protocol is designed as a single-arm,  prospec-
tive,  non-randomized,  non-comparative open-label study.
　 The procedure is performed under local anesthe-
sia.  The skin overlying the TMJ is scrubbed with 10  
povidone iodine and local anesthesia is induced with 
1  lidocaine containing 1/80000 epinephrine injected 
in the auricular fossa to block the auriculo-temporal 
nerve and the preauricular area.  The auricular fossa 
is located at a point 10mm anterior to the tragus of 
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Table 1　 Patient eligibility
Inclusion criteria
Aged 16 years or older
Diagnosed as having recurrent TMJ dislocation based on the clinical criteria of Nitzan [14].
Episodes of condylar dislocation for several times.
The conservative methods including restriction of the mandibular motions with chin cap,  facial bandage,  maxillomandibular ﬁxation,  or 
mouth opening training based on the self-reduce TMJ dislocation were ineﬀective.
Written informed consent
Exclusion criteria
Inﬂammatory diseases of temporomandibular joint,  such as rheumatoid arthritis,  tuberculous arthritis
Evidence of tumor or tumor like lesion in the TMJ
Temporomandibular disorders caused by metabolic diseases,  including crystal deposition diseases such as gout,  pseudogout,  or crystal 
arthritis
Intercurrent facial palsy
Serious concomitant systemic disorder,  including malignant hypertension,  history of severe cardiovascular diseases or cerebrovascular 
disorders within 6 months,  hemorrhagic gastric ulcers,  uncontrolled diabetes,  apparent bleeding tendency
Under anticoagulant therapy
Suspicion for active infection
History of serious psychiatric illness or psychiatry illness under medical treatment
Others diagnosed as inapplicable cases by an investigator
the ear and 2mm inferior to the tragal-canthal line.  At 
this location,  a 21-gauge needle is inserted into the 
superior joint space with the patientʼs mouth open.  
The resistance to needle progression will decrease 
when the needle tip enters the superior joint space.  
After conﬁrming correct needle placement,  the joint 
space is ﬂushed with 5ml of saline via a T-shaped 
stopcock.  The 21-gauge needle remains in position 
while 5ml of blood is collected into a syringe from the 
patientʼs antecubital fossa.  After connecting the blood 
syringe to the previously inserted needle,  3ml of 
blood is injected into the superior joint space; the 
needle is pulled outward 1cm,  and an additional 1ml 
of blood is injected into the pericapsular region (Fig.  
1A).  For bilateral,  recurrent TMJ dislocation,  the 
same procedure is performed on the opposite side.  
After the injections,  the patient must eat only soft 
foods for 7 days and reduce mouth opening with an 
elastic facial bandage (Fig.  1B).  If there is a relapse 
of TMJ dislocation,  autologous blood injection can be 
repeated.
Statistical Consideration
　 Postoperative consultations will occur at 1 week,  
2 weeks,  4 weeks,  3 months and 6 months post-opera-
tively up to the last appointment before data collec-
tion.  The follow-up parameters include clinical exami-
nation,  measuring the maximal incisal opening,  
assessment possible complications such as pain,  facial 
nerve paralysis,  frequency of condylar dislocation,  
recurrence rates and evaluation of the TMJ region by 
panoramic TMJ projection.  Visual analogue scale will 
be reported by patients to evaluate pain intensity.  For 
the assessment of facial nerve paralysis,  Yanagihara 
facial nerve grading system will be used.  The col-
lected data will be analyzed to assess the eﬃcacy and 
safety of autologous blood injection for management of 
recurrent TMJ dislocation by multivariate analysis and 
χ2 test.
Discussion
　 This study focuses on the eﬃcacy,  safety and sta-
bility of autologous blood injection for recurrent TMJ 
dislocation.  Autologous blood injection is a simple,  
outpatient procedure that is less time consuming than 
surgery,  minimally invasive and presents a low possi-
bility of risks.  We hope this procedure will prove to 
be a feasible alternative treatment for patients prior 
to any surgical intervention.
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Fig. 1　 TMJ autologous blood injection and postoperative care.  A,  Injection of 3ml of autologous blood into the superior joint space and 
1ml into the pericapsular region; B,  Elastic facial bandage applied to reduce mouth opening.
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